文献速递美容整形颅颌面外科乳房整形与再造

氨甲环酸在整形与重建外科中的作用:全国性视角

Role of tranexamic acid (TXA) in plastic and reconstructive surgery: A national perspective.
PubMed 文献 · J Plast Reconstr Aesthet Surg · 2024-11-30

本研究向美国整形外科医师学会(ASPS)全体活跃会员发放在线问卷,调查氨甲环酸(TXA)在整形与重建外科中的使用现状。502名会员完成调查(应答率21%),TXA最常用于美容手术(90.3%)、颅颌面手术(78.2%)和乳房再造(61.8%);最常见给药方案包括静脉推注(52.3%)和局部给药(50.5%),最常见静脉推注剂量为1 g(43.2%),最常见TXA溶液浓度为3%(36.0);92.4%的受访者报告从未观察到TXA相关并发症。

要点

  • TXA在ASPS会员中广泛使用,美容手术使用率最高(90.3%)。
  • 面部手术中,除皱术(83.6%)、颈部提升(77.1%)和鼻整形(55.0%)使用TXA较常见。
  • 92.4%的受访者报告从未观察到TXA相关并发症。

核心结论

  • 结果反映了TXA在ASPS会员中的广泛使用、整形外科中首选的给药方案,以及TXA在多种手术中的疗效和良好的安全性。

研究设计与样本

  • 向美国整形外科医师学会(ASPS)全体活跃会员发放在线问卷,调查TXA在整形与重建外科中的使用现状。
  • 问卷包括三部分:人口学数据与执业概况;对颅颌面外科、美容外科、烧伤护理、显微外科和Mohs手术等领域TXA的熟悉程度、认知和经验;TXA的剂量、给药方式和给药时间。
  • 502名ASPS会员完成调查,应答率为21%。

主要发现

  • TXA使用最常见于美容手术(90.3%)、颅颌面手术(78.2%)和乳房再造(61.8%)。
  • 使用TXA最常见的术式为面部手术,包括除皱术(83.6%)、颈部提升(77.1%)、额部及眉提升(54.8%)和鼻整形(55.0%)。
  • 美容手术中TXA给药方案包括静脉推注(52.3%)和局部给药(50.5%)。
  • 最常见的静脉推注剂量为1 g(43.2%),最常见的TXA溶液浓度为3%(36.0)。
  • 92.4%的受访者报告从未观察到任何TXA相关并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Despite the widespread use of tranexamic acid (TXA) in plastic surgery, guidelines for the safe and effective administration have yet to be established. The present study reports the current practices of TXA usage in plastic and reconstructive surgery procedures among members of the American Society of Plastic Surgeons (ASPS). METHODS: An online survey was distributed to all active members of the ASPS. The survey was organized into three general parts: (1) demographic data and practice profiles; (2) familiarity, perceptions, and experience with TXA in various plastic surgery fields including craniofacial surgery, aesthetic surgery, burn care, microsurgery, and Mohs surgery; and (3) TXA dosage, mode, and time of administration. RESULTS: Five hundred two ASPS members completed the survey (21% response rate). Among the respondents, TXA use was most common in aesthetic surgery (90.3%), craniofacial surgery (78.2%), and breast reconstruction (61.8%). The most common procedures performed under TXA were facial procedures, including facelift (83.6%), neck lift (77.1%), forehead and browlift (54.8%), and rhinoplasty (55.0%). TXA administration protocols in aesthetic procedures included IV bolus (52.3%) and topical administration (50.5%). The most common IV bolus dose was 1 g (43.2%) and the most common TXA solution concentration was 3% (36.0). A total of 92.4% of respondents reported that they had never observed any TXA-related complications. CONCLUSIONS: The results reflect the widespread use of TXA among ASPS members, the preferred administration protocols in plastic surgery, and TXA's efficacy and favorable safety profile across a wide range of procedures.

来源:J Plast Reconstr Aesthet Surg,查看原文。版权归原作者所有。

引用

  1. Rohrich RJ, Brown S, Brown T, et al. Role of tranexamic acid (TXA) in plastic and reconstructive surgery: A national perspective. J Plast Reconstr Aesthet Surg. 2024. PMID: 39965470. doi:10.1016/j.bjps.2024.09.085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。